Switch to:
More From Other Websites
Novogen Expands Board with Two New Appointments Jun 02 2015
Novogen Limited Announces Closing of Rights Issue Entitlement Offer and Notice of Shortfall Jun 01 2015
ATM Technology Extended with New Patent Lodgement May 27 2015
Novogen to Present at Brain Tumor Biotech Summit 2015 May 26 2015
Novogen to Present at the 2015 Marcum Microcap Conference May 25 2015
Novogen to Present at Hong Kong Investor Conference May 17 2015
Anisina Confirmed as Effective Anti-Cancer Agent in Animal Studies May 13 2015
Australian Studies Confirm TRXE-009 Kills Resistant Paediatric Brain Cancer Cells May 07 2015
Novogen Completes the Private Placement of Equity Apr 29 2015
Novogen Regains Full Compliance with NASDAQ Listing Rule Apr 27 2015
Novogen Posts Details on Rights Issue Offering for Shareholders Apr 26 2015
Cantrixil Receives Orphan Drug Designation from FDA Apr 21 2015
Novogen (NVGN) Stock Falls Today on Private Placement Apr 21 2015
Novogen taps investors for $30.5m Apr 21 2015
Novogen Conducts Private Placement and Announces Rights Offering to Shareholders Apr 20 2015
Novogen poised for capital raising Apr 20 2015
Cantrixil Highly Successful in Preventing Growth of Chemo-Resistant Ovarian Cancer Apr 20 2015
Novogen (NVGN) Stock Rises Today After Announcing Brain Cancer Treatment Collaboration Apr 17 2015
Novogen and Feinstein Institute Join Forces to Find Effective Treatments for Brain Cancer Apr 16 2015
Novagen (NVGN) Stock Spiked Today on Melanoma Treatment Study Results Apr 09 2015


Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

No comment yet


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GuruFocus Premium Plus Membership

FEEDBACK